BioNTech
BNTX
BNTX
278 hedge funds and large institutions have $4.71B invested in BioNTech in 2025 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 74 increasing their positions, 99 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 99
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
30% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 57
Holders
278
Holding in Top 10
5
Calls
$137M
Puts
$157M
Top Buyers
| 1 | +$63.3M | |
| 2 | +$52.9M | |
| 3 | +$50.8M | |
| 4 |
Millennium Management
New York
|
+$34M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$33.5M |
Top Sellers
| 1 | -$38.1M | |
| 2 | -$36.7M | |
| 3 | -$35.8M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$35.3M |
| 5 |
Primecap Management
Pasadena,
California
|
-$22.7M |
